Cargando…

A case report of clinical implications of a delayed antiretroviral therapy switch in a patient with multiple treatment interruptions

The Namibia national antiretroviral therapy guidelines recommend that patients living with HIV who interrupt antiretrovirals and in the process disengage from care be restarted on their usual antiretroviral therapy regimen upon return. We introduce a 39-year-old male patient on first-line antiretrov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kakubu, Mireille A Mpalang, Frans, Kandali, Gibutai, Nelson, Katoto, Patrick DMC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772926/ https://www.ncbi.nlm.nih.gov/pubmed/36569036 http://dx.doi.org/10.1177/2050313X221144209

Ejemplares similares

A Case Report of Multiclass HIV Drug-Resistance After an Inappropriate Switch of ARVs with Persistent Unsuppressed Viral Load
por: Kakubu, Mireille A Mpalang, et al.
Publicado: (2022)

Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report
por: Kakubu, Mireille A M, et al.
Publicado: (2023)

A miner with No left lung: Extensive pulmonary destruction in delayed effective Multi-Drug-Resistant Tuberculosis treatment
por: Katoto, Patrick D.M.C., et al.
Publicado: (2020)

Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination
por: Katoto, Patrick D. M. C., et al.
Publicado: (2023)

Integrating hypertension and HIV care in Namibia: A quality improvement collaborative approach
por: Basenero, Apollo, et al.
Publicado: (2022)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis
por: Katoto, Patrick DMC., et al.
Publicado: (2023)

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption
por: Hsu, Denise C., et al.
Publicado: (2021)

Prevalence and Impact of HIV Infections in Patients with Rheumatic Heart Disease: A Systematic Review and Meta-Analysis
por: Lumngwena, Evelyn N., et al.
Publicado: (2023)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
por: Bonney, Evelyn Y., et al.
Publicado: (2021)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

Changes in functional connectivity in people with HIV switching antiretroviral therapy
por: Toniolo, Sofia, et al.
Publicado: (2020)

Sex‐based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
por: Giles, Michelle L, et al.
Publicado: (2018)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study
por: Machado, Carmen, et al.
Publicado: (2012)

Immunological predictors of CD4(+ )T cell decline in antiretroviral treatment interruptions
por: Seoane, Elena, et al.
Publicado: (2008)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017)

1767. Structured Treatment Interruptions in HIV-Infected Patients Receiving Antiretroviral Therapy—Implications for Future HIV Cure Trials: A Systematic Review and Meta-analysis
por: Stecher, Melanie, et al.
Publicado: (2018)

Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon
por: Nsoh, Marius, et al.
Publicado: (2021)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
por: Paci, Paola, et al.
Publicado: (2009)

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2017)

Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA
por: Rakhmanina, Natella, et al.
Publicado: (2016)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
por: Fidler, S., et al.
Publicado: (2020)

Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?
por: Veenstra, Nina, et al.
Publicado: (2010)

Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal
por: Narainsamy, Denver, et al.
Publicado: (2017)

The Impact of Combination Antiretroviral Therapy and its Interruption on Anxiety, Stress, Depression and Quality of Life in Thai Patients
por: Nüesch, Reto, et al.
Publicado: (2009)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
por: Hill, Alison L., et al.
Publicado: (2016)

High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria
por: Ahonkhai, Aimalohi A., et al.
Publicado: (2015)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
por: Ventura, John D., et al.
Publicado: (2019)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
por: Maria, Suzy, et al.
Publicado: (2020)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
por: Li, Miaomiao, et al.
Publicado: (2021)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
por: Lau, Jillian SY., et al.
Publicado: (2021)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
por: Zacharopoulou, P., et al.
Publicado: (2022)

Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report
por: Parruti, Giustino, et al.
Publicado: (2005)

Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
por: Tabatabai, Julia, et al.
Publicado: (2014)

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model
por: Harris, Rebecca Arden, et al.
Publicado: (2018)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
por: Kroon, Eugène D.M.B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fc5l9hi9cr37ep27o8hplom8gl